Numerous reports have been published on the genetics of T2DM with most recent ones showcasing the effect of SNP’s in various genes corresponding to risk prediction of T2DM such as, gene variants of Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) [4-6], Angiotensin Converting Enzyme (ACE) [7-9], Methylene Tetrahydrofolate Reductase (MTHFR) [10-14], Fatty Acid Binding Protein-2 (FABP2) [15-19] and Fat Mass and Obesity associated gene (FTO) [20,21]. The gene discussed is FABP2; the disease is type 2 diabetes mellitus.